FOLFIRI.3
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for FOLFIRI.3, covering 2011-12-06 to 2011-12-06. Get the full timeline:
Most recent: Clinical Trial Update: Randomized Phase II Study of FOLFOX Versus FOLFIRI.3 in Gemcitabine-refractory Pancreatic Cancer [Phase 2]